AU747329B2 - Desformoterol and process for its preparation - Google Patents

Desformoterol and process for its preparation Download PDF

Info

Publication number
AU747329B2
AU747329B2 AU47072/99A AU4707299A AU747329B2 AU 747329 B2 AU747329 B2 AU 747329B2 AU 47072/99 A AU47072/99 A AU 47072/99A AU 4707299 A AU4707299 A AU 4707299A AU 747329 B2 AU747329 B2 AU 747329B2
Authority
AU
Australia
Prior art keywords
desformoterol
compound
formula
pharmaceutically acceptable
pct
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU47072/99A
Other languages
English (en)
Other versions
AU4707299A (en
Inventor
Chris Hugh Senanayake
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharma America Inc
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of AU4707299A publication Critical patent/AU4707299A/en
Application granted granted Critical
Publication of AU747329B2 publication Critical patent/AU747329B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/04—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reaction of ammonia or amines with olefin oxides or halohydrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/60—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU47072/99A 1998-06-23 1999-06-22 Desformoterol and process for its preparation Expired AU747329B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/103212 1998-06-23
US09/103,212 US5965622A (en) 1998-06-23 1998-06-23 Desformoterol and process for its preparation
PCT/US1999/014082 WO1999067198A1 (en) 1998-06-23 1999-06-22 Desformoterol and process for its preparation

Publications (2)

Publication Number Publication Date
AU4707299A AU4707299A (en) 2000-01-10
AU747329B2 true AU747329B2 (en) 2002-05-16

Family

ID=22293976

Family Applications (1)

Application Number Title Priority Date Filing Date
AU47072/99A Expired AU747329B2 (en) 1998-06-23 1999-06-22 Desformoterol and process for its preparation

Country Status (9)

Country Link
US (2) US5965622A (https=)
EP (1) EP1093450B1 (https=)
JP (1) JP4328021B2 (https=)
AT (1) ATE238271T1 (https=)
AU (1) AU747329B2 (https=)
CA (1) CA2335154C (https=)
DE (1) DE69907190T2 (https=)
ES (1) ES2193722T3 (https=)
WO (1) WO1999067198A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20010428A1 (it) * 2001-03-02 2002-09-02 Chemo Breath S A Composizioni ad uso inalatorio a base di formoterolo
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20030055026A1 (en) * 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US20040023935A1 (en) * 2002-08-02 2004-02-05 Dey, L.P. Inhalation compositions, methods of use thereof, and process for preparation of same
US20050158248A1 (en) * 2002-08-21 2005-07-21 Xian-Ming Zeng Method of preparing dry powder inhalation compositions
AU2003269989B8 (en) * 2002-08-21 2009-11-12 Norton Healthcare Ltd. Inhalation composition
GB0219511D0 (en) * 2002-08-21 2002-10-02 Norton Healthcare Ltd Method of preparing dry powder inhalation compositions
US20040109826A1 (en) * 2002-12-06 2004-06-10 Dey, L.P. Stabilized albuterol compositions and method of preparation thereof
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
WO2008035380A2 (en) * 2006-09-19 2008-03-27 Natco Pharma Limited An improved process for the preparation of high purity formoterol and its pharmaceutically acceptable salts
CN101391962A (zh) * 2007-09-21 2009-03-25 北京德众万全药物技术开发有限公司 一种高纯度的(R)-α-(溴甲基)-4-苄氧基-3-硝基苯甲醇及其制备方法
CN101462971B (zh) * 2007-12-19 2014-05-07 北京德众万全药物技术开发有限公司 高纯度的用于制备福莫特罗的关键中间体及其制备方法
ES2539947T3 (es) 2008-06-02 2015-07-07 Cipla Limited Procedimiento para la síntesis de arformoterol
WO2010128355A2 (en) 2008-12-26 2010-11-11 Actavis Group Ptc Ehf Improved processes for preparing substantially pure arformoterol and its intermediates
US8282512B1 (en) 2009-03-26 2012-10-09 Warrior Sports, Inc. Lacrosse head
CN101921200B (zh) * 2009-06-16 2014-01-15 上海医药工业研究院 一种n-苄基-1-(4-甲氧基苯基)-2-丙胺的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2031407A6 (es) * 1988-10-05 1992-12-01 Lasa Lab Mejoras introducidas en el objeto de la patente principal n{ 8703715 por: procedimiento de obtencion de n-(2-hidroxi-5-(1-hidroxi-2-((2-(4-metoxifenil)-1-metiletil)amino)etil)fenil)formamida".

Also Published As

Publication number Publication date
US5965622A (en) 1999-10-12
ATE238271T1 (de) 2003-05-15
CA2335154C (en) 2008-11-18
JP2002518468A (ja) 2002-06-25
AU4707299A (en) 2000-01-10
DE69907190T2 (de) 2004-02-12
EP1093450B1 (en) 2003-04-23
JP4328021B2 (ja) 2009-09-09
US6071971A (en) 2000-06-06
EP1093450A1 (en) 2001-04-25
CA2335154A1 (en) 1999-12-29
DE69907190D1 (de) 2003-05-28
ES2193722T3 (es) 2003-11-01
WO1999067198A1 (en) 1999-12-29

Similar Documents

Publication Publication Date Title
US6268533B1 (en) Formoterol process
AU747329B2 (en) Desformoterol and process for its preparation
AU722859B2 (en) Process for the preparation of optically pure isomers of formoterol
AU2009253877B2 (en) Process for the synthesis of arformoterol
JPH02200659A (ja) 鎮痛剤として有用な２‐アミノ‐４または５‐メトキシシクロヘキシルアミド
EP1426355B1 (en) Crystals of hydroxynorephedrine derivative
WO2011034849A1 (en) Novel compounds advantageous in the treatment of central nervous system diseases and disorders
WO2010128355A2 (en) Improved processes for preparing substantially pure arformoterol and its intermediates
EP2195285B1 (en) Acetamide stereoisomer
AU748508B2 (en) Formoterol polymorphs
JP4049826B2 (ja) 新規ベンジルアミン誘導体及びフェニルエチルアミン誘導体、それらの製造方法及び医薬組成物としての使用
JPH02286650A (ja) 新規な気管支痙攣鎮痙化合物およびその製法

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired